The average stock forecast for Marinus Pharmaceuticals Inc (MRNS) is USD. This price target corresponds to an upside of %. According to analysts, MRNS price target is USD with a max estimate of USD and a min estimate of USD. Stable Share Price: MRNS has not had significant price volatility in the past 3 months. Volatility Over Time: MRNS's weekly volatility (11%) has been stable. MRNS Price Targets Summary. Marinus Pharmaceuticals Inc Wall Street analysts forecast MRNS stock price to rise over the next 12 months. According to Wall. The Marinus Pharmaceuticals stock prediction for is currently $ , assuming that Marinus Pharmaceuticals shares will continue growing at the average.
price targets ranging from $9 to $ Price: , Change: , Percent Pharmaceuticals. Market Closed - Nasdaq. Other stock markets. 14/ The current price of MRNS is USD — it has increased by % in the past 24 hours. Watch Marinus Pharmaceuticals, Inc. stock price performance more closely. The average price target is $ with a high estimate of $11 and a low estimate of $2. Sign in to your SmartPortfolio to see more analyst recommendations. Marinus Pharmaceuticals (MRNS) stock price prediction is USD. The Marinus Pharmaceuticals stock forecast is USD for On Aug 14, major Wall Street analysts update their ratings for $Marinus Pharmaceuticals(lunarland.ru)$, with price targets ranging from $3 to $TD Cowen analyst. MRNS's current price target is $ Learn why top analysts are making this stock forecast for Marinus Pharmaceuticals at MarketBeat. Marinus Pharma stock surges 49% on positive mid-stage data for pediatric epilepsy drug. Marinus Pharmaceuticals Inc. shares surged % to $ per share in. Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare. Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. Average Price Target ; High $ ; Average $ ; Low $ Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of % and %, respectively, for the quarter ended June Do the numbers hold.
Get Marinus Pharmaceuticals Inc (MRNS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. The average one-year price target for Marinus Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ Marinus Pharmaceuticals Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. The average Marinus Pharmaceuticals stock price prediction forecasts a potential upside of % from the current MRNS share price of $ Hold. 0 ; Current $ ; Target $ ; Technicals Summary. Sell. Neutral. Buy. Marinus Pharmaceuticals Inc is currently not in a favorable trading position . Stock Price Target. High, $ Low, $ Average, $ Current Price, $ MRNS will report FY earnings on 03/11/ Yearly Estimates. The 6 analysts with month price forecasts for MRNS stock have an average target of , with a low estimate of and a high estimate of Based on short-term price targets offered by eight analysts, the average price target for Marinus Pharmaceuticals comes to $ The forecasts range from a low.
These share price targets are working as support & resistance levels as well. Marinus Pharmaceuticals MRNS share price forecast & targets for mid-term is a. View Marinus Pharmaceuticals Inc MRNS stock quote prices, financial information, real-time forecasts, and company news from CNN. Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is. Marinus Pharmaceuticals Inc MRNS ; - , - , , The Marinus Pharmaceuticals Inc stock price today is What Is the Stock Symbol for Marinus Pharmaceuticals Inc? The stock ticker symbol for Marinus.
MRNS Price · $ ; Market Cap · $M ; 52 Week Low · $ ; 52 Week High · $ ; P/E · x. Analyst Forecast. According to 6 analysts, the average rating for MRNS stock is "Buy." The month stock price forecast is $, which is an increase of. Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today. Investors are thrilled with the results from a late-stage clinical study of the company's only.
Best Individual Retirement Account | Price Of Dog Dna Test